You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 59 Next »

This example shows the findings of a cardiac magnetic resonance imaging procedure related to late gadolinium enhancement. The level of granularity varies with the type of test used; research requirements will determine what level of granularity is needed.

The procedures (PR) domain contains interventional activity intended to have diagnostic, preventive, therapeutic, or palliative effects. The example PR dataset below shows the cardiac magnetic resonance imaging with two different MRI machines. The variable SPDEVID is used to represent the imaging device identifier information provided in the DI dataset below. For more information on this domain, see Section 6.1.5, Procedures (PR), in the SDTMIG v3.4.

Row 1:Shows the results of a cardiac MRI for participant DMD-EFLGE-01-101.
Row 2:Shows the results of a cardiac MRI for participant DMD-EFLGE-01-202 with a different MRI machine. The time of the procedure was not available so only the date is shown in the PRSTDTC variable.

pr.xpt

pr.xpt

Row

STUDYID

DOMAIN

USUBJID

PRSEQ

SPDEVID

PRREFID

PRLNKID

PRTRT

PRFAST

PRSTDTC

1

DMD-EFLGE

PR

DMD-EFLGE-01-101

1

ABC001

12345678

04

CARDIAC MAGNETIC RESONANCE IMAGING

Y

2023-07-01T09:15:00

2

DMD-EFLGE

PR

DMD-EFLGE-01-202

1

ABC002

98765432

05

CARDIAC MAGNETIC RESONANCE IMAGING

N

2023-07-05

$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

The example CV dataset below shows the results of the LGE test measured using cardiac magnetic resonance (CMR) imaging. The analysis method describes the method of secondary processing applied to a complex observation result (e.g., an image, a genetic sequence). There may be machine-centric analysis methods inherit to the type of machine (e.g., full-width half maximum, 5 standard deviations, 6 standard deviations). (Ref: https://jcmr-online.biomedcentral.com/articles/10.1186/1532-429X-12-21). If this information is of interest to the study, it would be represented using the CVANMETH variable.
Row 1:Shows the late gadolinium enhancement is positive for participant DMD-EFLGE-01-101.
Row 2:Shows the total late gadolinium enhancement percentage is 40%.
Rows 3-19:Show segmental late gadolinium enhancement results for each of the left ventricle segments.
Row 20:Shows the late gadolinium enhancement segment count.
Rows 21-24:Show the segmental late gadolinium enhancement percentage for each of the positive segments.
Row 25:Shows the late gadolinium enhancement is negative for participant DMD-EFLGE-01-202.

cv.xpt

cv.xpt

Row

STUDYID

DOMAIN

USUBJID

CVSEQ

CVLNKID

CVTESTCD

CVTEST

CVORRES

CVORRESU

CVSTRESC

CVSTRESN

CVSTRESU

CVLOC

CVMETHOD

CVLOBFXL

CVANMETH

VISITNUM

VISIT

CVDTC

1DMD-EFLGECVDMD-EFLGE-01-101104LGELATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



HEART, LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
2DMD-EFLGECVDMD-EFLGE-01-101204TLGEPERTOTAL LATE GADOLINIUM ENHANCEMENT PERCENTAGE

40

%

40

40%HEART, LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
QUANTITATIVE1VISIT 12023-07-01
3DMD-EFLGECVDMD-EFLGE-01-101304SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENTNEGATIVE

NEGATIVE



LEFT VENTRICULAR BASAL ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
4DMD-EFLGECVDMD-EFLGE-01-101404SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
5DMD-EFLGECVDMD-EFLGE-01-101504SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT

CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
6DMD-EFLGECVDMD-EFLGE-01-101604SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR BASAL INFERIOR SEGMENT

CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
7DMD-EFLGECVDMD-EFLGE-01-101704SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT

CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
8DMD-EFLGECVDMD-EFLGE-01-101804SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
9DMD-EFLGECVDMD-EFLGE-01-101904SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
10DMD-EFLGECVDMD-EFLGE-01-1011004SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
11DMD-EFLGECVDMD-EFLGE-01-1011104SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR MID INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
12DMD-EFLGECVDMD-EFLGE-01-1011204SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
13DMD-EFLGECVDMD-EFLGE-01-1011304SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID INFEROLATERAL SEGMENT

CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
14DMD-EFLGECVDMD-EFLGE-01-1011404SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT

CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
15DMD-EFLGECVDMD-EFLGE-01-1011504SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
16DMD-EFLGECVDMD-EFLGE-01-1011604SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL SEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
17DMD-EFLGECVDMD-EFLGE-01-1011704SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
18DMD-EFLGECVDMD-EFLGE-01-1011804SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL LATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
19DMD-EFLGECVDMD-EFLGE-01-1011904SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APEX SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
20DMD-EFLGECVDMD-EFLGE-01-1012004LGESEGCLATE GADOLINIUM ENHANCEMENT SEGMENT COUNT

4


4

4
HEART, LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-01
21DMD-EFLGECVDMD-EFLGE-01-1012104LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

40

%

40

40%LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM1VISIT 12023-07-01
22DMD-EFLGECVDMD-EFLGE-01-1012204LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

20

%

20

20%LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM1VISIT 12023-07-01
23DMD-EFLGECVDMD-EFLGE-01-1012304LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

45

%

45

45%LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM1VISIT 12023-07-01
24DMD-EFLGECVDMD-EFLGE-01-1012404LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

20

%

20

20%LEFT VENTRICULAR INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM1VISIT 12023-07-01
25DMD-EFLGECVDMD-EFLGE-01-202105LGELATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



HEART, LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGING
VISUAL1VISIT 12023-07-05
$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

The procedure agents (AG) domain contains the agents administered to the subject as part of a procedure or assessment. For more information on this domain, see Section 6.1.1, Procedure Agents (AG), in the SDTMIG v3.4. The example AG dataset below shows the timing of the gadolinium-based contrast, 'Gd-DOTA'. The time the contrast was given to participant DMD-EFLGE-01-202 was not available, so only the date is represented in AGSTDTC variable.

ag.xpt

ag.xpt

Row

STUDYID

DOMAIN

USUBJID

AGSEQ

AGLNKID

AGTRT

AGCAT

AGDOSE

AGDOSU

AGDOSFRM

AGROUTE

VISITNUM

AGSTDTC

1

DMD-EFLGE

AG

DMD-EFLGE-01-101

1

04

Gd-DOTA

CONTRAST AGENT

8

mL

SOLUTION

INTRAVENOUS

VISIT 1

2023-07-01T09:25:00

2

DMD-EFLGE

AG

DMD-EFLGE-01-202

2

04

Gd-DOTA

CONTRAST AGENT

10

mL

SOLUTION

INTRAVENOUS

VISIT 1

2023-07-05

$warningHtml

  • No labels